IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer
Nadine Bley(Luther University), Stefan Hüttelmaier(Martin Luther University Halle-Wittenberg), Claudia Wickenhauser, Markus Glaß(Luther University), Chris Aßmann(Luther University), Tommy Fuchs(Luther University), Olga Ungurs(Luther University), Danny Misiak(Luther University), Annekatrin Schott(Luther University), Simon Müller(Martin Luther University Halle-Wittenberg), Christian Ihling(University of Stuttgart), Nikolaos Pazaitis(Luther University), Andrea Sinz(Luther University), Marcell Lederer(Luther University), Christoph Thomssen(Martin Luther University Halle-Wittenberg), Hans‐Georg Strauß(Martin Luther University Halle-Wittenberg), Martina Vetter(Martin Luther University Halle-Wittenberg)
Cited by 55
Related Papers
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k
4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
|Annals of Oncology|2018|1.2k
Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?
|Cellular and Molecular Life Sciences|2012|805
Chemical cross‐linking and mass spectrometry to map three‐dimensional protein structures and protein–protein interactions
|Mass Spectrometry Reviews|2006|662